DarioHealth Corp.
DRIO
$7.99
$0.496.53%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 4.47% | -6.74% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 4.47% | -6.74% | |||
| Cost of Revenue | 24.02% | -8.16% | |||
| Gross Profit | -6.60% | -5.92% | |||
| SG&A Expenses | -4.79% | 8.62% | |||
| Depreciation & Amortization | 0.00% | -58.20% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -4.82% | -0.54% | |||
| Operating Income | 9.72% | -3.09% | |||
| Income Before Tax | 14.50% | 19.43% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 13.71% | 19.43% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 13.71% | 19.43% | |||
| EBIT | 9.72% | -3.09% | |||
| EBITDA | 10.18% | -6.43% | |||
| EPS Basic | 31.13% | 16.43% | |||
| Normalized Basic EPS | 66.08% | 36.28% | |||
| EPS Diluted | 31.13% | 16.43% | |||
| Normalized Diluted EPS | 66.08% | 36.28% | |||
| Average Basic Shares Outstanding | 152.08% | 26.46% | |||
| Average Diluted Shares Outstanding | 152.08% | 26.46% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||